[
  {
    "ts": null,
    "headline": "Jim Cramer on Johnson & Johnson: “I Think It’s a Terrific Entry Point”",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer offered insights on. Cramer highlighted the company’s latest spin-off plans for one of its divisions, as he commented: “The fastest grower, the best opportunity here would not be Eli Lilly, which has moved a great deal and I still like, but Johnson & Johnson. […]",
    "url": "https://finnhub.io/api/news?id=bba4de0690500d2b1c69720b1269471493564386b4cfb4c10b8abffc454c4e8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767876310,
      "headline": "Jim Cramer on Johnson & Johnson: “I Think It’s a Terrific Entry Point”",
      "id": 138036593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer offered insights on. Cramer highlighted the company’s latest spin-off plans for one of its divisions, as he commented: “The fastest grower, the best opportunity here would not be Eli Lilly, which has moved a great deal and I still like, but Johnson & Johnson. […]",
      "url": "https://finnhub.io/api/news?id=bba4de0690500d2b1c69720b1269471493564386b4cfb4c10b8abffc454c4e8c"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Kenvue (KVUE) After Share Price Slide And Johnson & Johnson Separation",
    "summary": "If you are wondering whether Kenvue's current share price reflects fair value or a potential opportunity, you are in the right place. The stock closed at US$16.74 with returns of a 3.0% decline over 7 days, a 0.1% decline over 30 days, a 3.3% decline year to date and a 17.4% decline over the last year, which may have shifted how investors think about its risk and return trade off. Recent coverage around Kenvue has focused on its position as a stand alone consumer health company following its...",
    "url": "https://finnhub.io/api/news?id=8c1261a84ec42904081ecb3494b2265cdb2f062a8d459842b8fe92b1d40f464e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767870441,
      "headline": "Assessing Kenvue (KVUE) After Share Price Slide And Johnson & Johnson Separation",
      "id": 138034989,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "If you are wondering whether Kenvue's current share price reflects fair value or a potential opportunity, you are in the right place. The stock closed at US$16.74 with returns of a 3.0% decline over 7 days, a 0.1% decline over 30 days, a 3.3% decline year to date and a 17.4% decline over the last year, which may have shifted how investors think about its risk and return trade off. Recent coverage around Kenvue has focused on its position as a stand alone consumer health company following its...",
      "url": "https://finnhub.io/api/news?id=8c1261a84ec42904081ecb3494b2265cdb2f062a8d459842b8fe92b1d40f464e"
    }
  },
  {
    "ts": null,
    "headline": "The Bull Case For Kenvue (KVUE) Could Change Following New Asia-Pacific CMO Appointment - Learn Why",
    "summary": "Kenvue has appointed Madhav Nayak as Vice President and Chief Marketing Officer for the Asia-Pacific region, bringing experience from Yum! Brands, Meta and a more than 12-year tenure at Unilever into its regional leadership team. This hire could meaningfully influence how Kenvue executes its marketing, digital and commercial agenda across Asia-Pacific, a core growth-focused geography for the consumer health group. We will now explore how Madhav Nayak’s appointment as Asia-Pacific CMO might...",
    "url": "https://finnhub.io/api/news?id=34699dee86953ea5dc4289e40f5346fb5313f224cde36a212d9723691707b41c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767841848,
      "headline": "The Bull Case For Kenvue (KVUE) Could Change Following New Asia-Pacific CMO Appointment - Learn Why",
      "id": 138032981,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Kenvue has appointed Madhav Nayak as Vice President and Chief Marketing Officer for the Asia-Pacific region, bringing experience from Yum! Brands, Meta and a more than 12-year tenure at Unilever into its regional leadership team. This hire could meaningfully influence how Kenvue executes its marketing, digital and commercial agenda across Asia-Pacific, a core growth-focused geography for the consumer health group. We will now explore how Madhav Nayak’s appointment as Asia-Pacific CMO might...",
      "url": "https://finnhub.io/api/news?id=34699dee86953ea5dc4289e40f5346fb5313f224cde36a212d9723691707b41c"
    }
  }
]